Humana Press eBooks · 2003 · 79 citations · 40 references
Veterinary MedicineInfectious DiseasesMicrobiologyImmunizationMedical MicrobiologyVaccinologyBacterial ImmunologySubunit VaccinesVaccinationVaccine DeliveryVaccine FormulationVaccine PlatformsAntibodiesBacterial VaccinationBacterial Vaccine AntigensBacterial VaccinesBactericidal AgentsCell Surface ProteinsOuter Membrane ProteinsOuter Membrane Vesicle Vaccine
Alternative strategies exist for prevention of group B Neisseria meningitidis (meningococcal) disease through vaccination (see Chapters 5 , 8 , 13 , 14 in this volume). However, the most promising approach to date has been the use of outer-membrane vesicle (OMV) vaccines for induction of bactericidal antibodies against cell-surface outer-membrane proteins (OMPs).
40
Immunogenicity of 2 Serogroup B Outer-Membrane Protein Meningococcal Vaccines
Jordan W. Tappero, A. Maldonado Ballesteros, D Williams et al. · JAMA · 1999 · 371 citations
Noni E. MacDonald, Scott A. Halperin, B J Law et al. · JAMA · 1998 · 249 citations
Medicine, Immunology, Pediatrics +17